Lancer Orthodontics Inc (LANZ) fair value: what the stock is really worth
We calculate from audited financials what Lancer Orthodontics Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jun 24, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch Lancer Orthodontics Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 24, 2026.
How to read this chart
60‑month range $0.0015 – $0.4000 · fair‑value band $0.0100 – $0.0200 · the $0.0400 price screens above the $0.0100 fair value. Dashed = 300-day average. As of Jun 24, 2026.
Follow Lancer Orthodontics in your weekly email
Every Wednesday you see whether Lancer Orthodontics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products.
Show more
Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists worldwide. It offers aesthetic brackets, brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and miscellaneous products. The company was founded in 1967 and is based in Vista, California.
Stock analysis
Lancer Orthodontics Inc (LANZ) currently trades at $0.0400, while our model-based Fair Value estimate is $0.0100, 75.0% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 12 models at a data quality of 88/100, which puts the evidence level at low.
Scenario range: $0.0100 (bear) to $0.0200 (bull), the price of $0.0400 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Lancer Orthodontics Inc reported revenue of $6.0M in FY2004 versus $5.7M in FY2000, a compound +1.6%/yr. Reported net income was $29.0K in FY2004.
Key figures
Market cap $42.8M · P/S ratio 6.92 · Net margin 0.5% · Return on equity 3.3% · Return on assets (EBIT) 4.0% · Operating margin −5.5% · Revenue (TTM) $6.2M · Revenue growth (YoY) +12.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades at its 52-week high and 2,567% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −37% fair-value upside, at −75%, LANZ screens richer than that median.
Notify me when LANZ reaches fair value
Put LANZ on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.15/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+2.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.6%
’93
’94
’95
’96
’97
’98
’99
’00
’01
’02
’03
’04
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−37.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−37.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−37.3% vs −19.1%, slowing
Profit margin 1999 to 2004 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 1%
⚠ Revenue per share shrinking 3.3%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Lancer Orthodontics Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 191 stocks
Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score37 · Bottom 25%
Profitability
Return on equity (TTM)3.3% · Below median
Return on assets0.5% · Bottom 25%
Net margin (TTM)1.7% · Below median
Operating margin (TTM)−5.5% · Bottom 25%
Growth and dividend
Revenue growth12.3% · Above median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 25
FUTURE (revenue growth)62· sector 36
PAST (return on equity)13· sector 27
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 32
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Lancer Orthodontics Inc (LANZ) overvalued or undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0100 versus the last price from Sep 25, 2026 of $0.0400, about −75% upside (overvalued).
What is the fair value of LANZ?
Our model-based fair value for Lancer Orthodontics Inc is $0.0100 (as of Jun 24, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.0400.
What is the quality score of LANZ?
Lancer Orthodontics Inc has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lancer Orthodontics Inc (LANZ)?
Our model-based price target is the fair value of $0.0100 (as of Jun 24, 2026) from 12 valuation models. Cautious scenario $0.0100, optimistic scenario $0.0200. It is a calculation from audited fundamentals, not an analyst target.
What is the Lancer Orthodontics Inc stock forecast for 2026?
Our models put fair value at $0.0100, about −75% upside versus the last price from Sep 25, 2026 of $0.0400 (overvalued). Cautious scenario $0.0100, optimistic scenario $0.0200. The calculation is refreshed regularly with new filings.
What is the revenue of Lancer Orthodontics Inc (LANZ)?
Lancer Orthodontics Inc reported trailing-twelve-month revenue of about $6.2M (latest available figure, as of Jun 24, 2026).
What is the intrinsic value of Lancer Orthodontics Inc (LANZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lancer Orthodontics Inc it is $0.0100 per share (as of Jun 24, 2026), against a price of $0.0400. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Lancer Orthodontics Inc stock overvalued or undervalued in 2026?
As of Jun 24, 2026, LANZ trades above its calculated fair value: price $0.0400, fair value $0.0100, a gap of about −75% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LANZ?
No. The price is what the market pays today ($0.0400); the fair value is what the company's own numbers justify ($0.0100). For Lancer Orthodontics Inc the two are $0.0300 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lancer Orthodontics Inc worth?
The market values Lancer Orthodontics Inc at about $42.8M (market capitalisation, as of Jun 24, 2026). Per share that is $0.0400; our models calculate a fair value of $0.0100 per share.
What do the bullish and bearish scenarios say about LANZ?
Our models span a range for Lancer Orthodontics Inc: cautious scenario $0.0100, base $0.0100, optimistic $0.0200 per share (as of Jun 24, 2026, price $0.0400). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Lancer Orthodontics Inc (LANZ)?
Balance-sheet figures for Lancer Orthodontics Inc (as of Jun 24, 2026): return on equity 3.3%. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is LANZ from its 52-week high?
Lancer Orthodontics Inc trades at $0.0400, at its 52-week high of $0.0400 and 2,567% above the low of $0.0015 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0100 is for.
Which stocks are comparable to Lancer Orthodontics Inc?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lancer Orthodontics Inc stock attractive at the current price?
The data as of Jun 24, 2026: price $0.0400, calculated fair value $0.0100 (−75%), Quality Score 37/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LANZ calculated?
We run Lancer Orthodontics Inc through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Lancer Orthodontics Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lancer Orthodontics Inc (LANZ)?
The latest price we hold is from Sep 25, 2026 and stands at $0.0400. Our model-based fair value is $0.0100, about −75% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lancer Orthodontics Inc right now?
The price sits above even our optimistic bull case ($0.0200). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.0100 to $0.0200) leaves room in how you read the outcome.
Key figures of Lancer Orthodontics Inc
How large is the market capitalisation of Lancer Orthodontics Inc (LANZ)?
The market capitalisation of Lancer Orthodontics Inc is $42.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lancer Orthodontics Inc (LANZ)?
The price-to-sales ratio of Lancer Orthodontics Inc is 6.92 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Lancer Orthodontics Inc (LANZ)?
The net margin of Lancer Orthodontics Inc is 0.5% (fiscal year 2004). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lancer Orthodontics Inc (LANZ)?
The return on equity (ROE) of Lancer Orthodontics Inc is 3.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lancer Orthodontics Inc (LANZ)?
On an EBIT basis the return on assets of Lancer Orthodontics Inc is 4.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lancer Orthodontics Inc (LANZ)?
The operating margin of Lancer Orthodontics Inc is −5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lancer Orthodontics Inc (LANZ)?
Revenue at Lancer Orthodontics Inc is growing +12.3% versus a year earlier (3y avg +0.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Lancer Orthodontics Inc (LANZ) generate?
The free cash flow of Lancer Orthodontics Inc is −$471K (fiscal year 2004). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Lancer Orthodontics Inc (LANZ) hold?
Lancer Orthodontics Inc holds more cash than debt, $304K net (fiscal year 2004). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Lancer Orthodontics Inc in the live analysis
One click puts Lancer Orthodontics Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Jun 24, 2026